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ABSTRACT: Two short glycol nucleic acid (GNA) oligonucleotides, having either a terminal or an 
intrachain nucleobase replaced by the pyridine-2,6-dicarboxamide chelate of Pd2+, have been 
synthesized and their hybridization properties studied by melting temperature measurements. In the 
termini of a double-stranded oligonucleotide, the Pd2+ chelates provided dramatic stabilization of 
the duplex relative to its metal-free counterpart, in all likelihood owing to formation of Pd2+-
mediated base pairs between pyridine-2,6-dicarboxamide and the opposing nucleobase. In contrast, 
no stabilization was observed when the Pd2+ chelate was placed in the middle of the chain. 
Furthermore, the results could not be reproduce by adding a Pd2+ salt in situ to the dilute 
oligonucleotide solutions but the palladated oligonucleotides had to be synthesized and purified 
prior to the hybridization studies. This behavior, presumably attributable to the relatively slow 
ligand-exchange reactions of Pd2+, differs greatly from what is usually observed with more labile 
metal ions. The present results offer an explanation for the failure of previous attempts to 
incorporate Pd2+-mediated base pairs into oligonucleotides. 
 
1. Introduction 
 Metal-ion-mediated base pairing of nucleic acids has been studied extensively for more than 
a decade owing to its potential in DNA nanotechnology and in expanding the genetic alphabet.[1-9] 
So far, the most promising results have been obtained with the kinetically labile Ag+, Hg2+ or Cu2+ as 
the bridging metal ion. For expanding the range of applications of metal-ion-mediated base pairing 
to chemotherapy, however, the low intracellular concentrations of these metal ions present a severe 
limitation. DNA cross-linking by the kinetically inert Pt2+, in turn, is a widely employed strategy in 
cancer chemotherapy[10-12] but suffers from low sequence-specificity. Oligonucleotides capable of 
metal-ion-mediated hybridization even under the metal-deficient conditions of the cell would offer 
an elegant solution to this problem. 
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 Along with Pt2+, Pd2+ appears an ideal candidate for metal-ion-mediated base pairing. Both of 
these metal ions prefer nitrogen over oxygen ligands and form highly stable square-planar 
complexes that are compatible with the steric requirements of the base stack of a double-helical 
nucleic acid. At monomeric level, several Pd2+-mediated base pairs have been described in the 
literature.[13-19] In fact, the very first artificial metal-ion-mediated base pair was formed through 
coordination of Pd2+.[20] Incorporation of a Pd2+-mediated base pair into an oligonucleotide, 
however, remains to be convincingly demonstrated. The apparent discrepancy between the results 
obtained at monomer and oligomer levels may be understood in terms of the relatively slow ligand 
exchange reactions of Pd2+. A double-helical oligonucleotide presents many potential donor atoms 
and a Pd2+ ion introduced in situ may well remain kinetically trapped at a nonproductive binding site. 
 In this article we present compelling evidence for Pd2+-mediated base pairing within an 
oligonucleotide. K2PdCl4 was allowed to react with short glycol nucleic acid (GNA) oligonucleotides 
incorporating a single high-affinity ligand. The GNA backbone was chosen as a test bed because of 
the relatively easy and facile synthesis of modified GNA building blocks. The metallated 
oligonucleotides were purified by RP HPLC before hybridization experiments. Coordination of a 
single Pd2+ ion by the modified oligonucleotides was verified by mass spectrometric analysis. 
Thermal melting studies with these oligonucleotides revealed the Pd2+-mediated base pair to be 
better tolerated in a terminal than in an internal position. 
 
2. Results and discussion 
2.1. Building block synthesis 
 The GNA phosphoramidite building blocks of the four canonical nucleobases were prepared 
as described previously.[21-23] For preparation of a respective building block of the metal-ion-
chelating residue (1), the phenolic OH function of diethyl 4-hydroxypyridine-2,6-dicarboxylate was 
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first derivatized by treatment with (R)-2,2-dimethyl-1,3-dioxolane-4-methanol p-toluenesulfonate 
(Scheme 1). The isopropylidine protection was then removed under acidic conditions and the 
liberated primary OH function was protected as a 4,4´-dimethoxytrityl ether. The secondary OH of 
the protected intermediate 3 was phosphitylated by conventional methods. Finally, the 
ethoxycarbonyl substituents of the pyridine ring were converted to aminocarbonyl substituents by 
treatment with methanolic ammonia to afford the phosphoramidite building block 1. It is worth 
pointing out that GNA oligonucleotides with free OH termini will undergo cleavage under these 
conditions. 
< Scheme 1 > 
 
2.2. Preparation of solid supports for the synthesis of GNA oligonucleotides 
 For immobilization on solid support, protected GNA counterparts of the canonical 2´-
deoxynucleosides were first succinylated by treatment with succinic anhydride in anhydrous pyridine 
(Scheme 2). The crude products were then attached to long chain alkylamine-functionalized 
controlled pore glass (LCAA-CPG) by conventional HBTU-promoted peptide coupling. Based on trityl 
response on treatment with 3% dichloroacetic acid in CH2Cl2, loadings of the solid supports thus 
obtained were found to be in the typical range (30 – 50 μmol g-1). 
< Scheme 2 > 
 
2.3. Oligonucleotide synthesis 
 The oligonucleotides (Table 1) were assembled by an automated synthesizer on a CPG-
supported succinyl linker. Standard phosphoramidite strategy with 300 s coupling time (with 5-
benzylthio-1H-tetrazole as the activator) was used throughout the sequences. Based on the trityl 
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response, the coupling yields were 44% for the modified building block 1 and more than 98% for the 
other building blocks. The oligonucleotides were released from the supports and the phosphate and 
base protections removed by treatment with either 16% aq. ammonia (for ON1 and ON2) or 20% aq. 
methylamine (for ON3) for 35 min at 55 °C. To minimize cleavage of the phosphodiester linkages, the 
aminolyses were carried out with the 3´-O-DMTr protection in place. This protecting group was 
finally removed in 80% aq. acetic acid (60 min at room temperature). 
< Table 1 > 
The crude oligonucleotides were purified by RP-HPLC and the purified products characterized by 
electrospray ionization mass spectrometry (ESI-MS). The concentrations of the oligonucleotides 
were estimated UV-spectrophotometrically based on absorbance at 260 nm. The molar 
absorptivities were calculated by an implementation of the nearest-neighbors method assuming the 
hypochromicities of GNA and DNA oligonucleotides to be equal.[24, 25] For determination of the 
molar absorptivity of the modified residue, compound 3 was deprotected and converted into the 
diamide 5 by successive treatments with hydrochloric acid and methanolic ammonia (Scheme 3). 
Molar absorptivity of 5 at 260 nm was determined to be 2000 M-1 cm-1 (UV spectrum presented as 
supporting information). 
< Scheme 3 > 
 
2.4. Preparation of Pd2+-carrying oligonucleotides 
 Oligonucleotide ON1, bearing the modified residue 5 in its 5´-terminus, was dissolved in 2 
mM aq. K2PdCl4, to a final concentration of 1.3 mM. This mixture was incubated overnight at room 
temperature, after which it was diluted with phosphate buffer (pH 7.2). The product mixture was 
fractioned by RP-HPLC eluting with an MeCN gradient in phosphate buffer and the collected 
fractions desalted by RP-HPLC eluting with an MeCN gradient in water. Based on the HPLC profile, 
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ON1 had been converted nearly quantitatively to products of lower mobility (Fig. 1). ESI-MS analysis 
revealed the main product, eluting at 12.5 min, to be a complex of two ON1 molecules and two Pd2+ 
ions (Fig 2., ON12:Pd2). Each of the Pd
2+ ions had displaced two protons, consistent with the binding 
mode reported previously for pyridine-2,6-dicarboxamide.[18] Given the self-complementarity of 
the tetranucleotide sequence in the middle of ON1, a homoduplex with terminal Pd2+-mediated base 
pairs between the pyridine-2,6-dicarboxamide moiety of the modified residue 5 and thymine 
appears the most likely structure for ON12:Pd2. Coordination of Pd
2+ to the N3 atom of thymine is 
accompanied by deprotonation,[18] resulting in a net charge of -1 for each of the Pd2+-mediated 
base pairs. Based on ESI-MS, the second-most abundant product, eluting at 13.8 min, appeared to 
consist of three ON1 molecules and three Pd2+ ions (data not shown). The other minor products 
remained unidentified. 
< Figure 1 > 
< Figure 2 > 
Oligonucleotide ON2, incorporating the modified residue 5 in the middle of the sequence, was 
dissolved in 2 mM aq. K2PdCl4 , to a final concentration of 1.8 mM. This mixture was incubated 
overnight at room temperature, after which it was freeze-dried. An equimolar amount of the 
complementary oligonucleotide ON3 was then added and the mixture diluted with phosphate buffer 
(pH 7.2). The RP-HPLC chromatogram of the product mixture (Fig. 3) consisted of two main peaks, of 
which the slower eluting one (tR = 13.0 min) was identified as ON3 by HPLC-MS analysis, as well as 
spiking with an authentic sample. The faster-eluting peak (tR = 10.3 min), in turn, did not correspond 
to either of the starting oligonucleotides. In fact, hardly any unreacted ON2 could be detected in the 
product mixture. When small volumes of the mixture were injected, the areas of the two peaks were 
approximately equal but upon injection of larger volumes the first peak grew at the expense of the 
second one (chromatograms presented as supporting information). Evidently the two peaks 
represented two compounds in equilibrium and increasing the concentration shifted this equilibrium 
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to favor the faster-eluting compound. The most likely explanation for such behavior is that the first 
peak, eluting faster than either ON2 or ON3, corresponded to a heterodimer of these 
oligonucleotides. This interpretation was confirmed by reinjection of the collected peak – in this 
chromatogram, peaks of the fast-eluting product and oligonucleotide ON3, but not ON2, were 
detected (Fig. 3D). The absence of the peak of ON2 could be explained if ON2 eluted as the Pd2+ 
complex ON2:Pd and the retention time of this metallo-oligonucleotide was very similar to that of 
the heterodimer product.  Attempts to desalt the product fraction were unsuccessful, presumably 
due to denaturation of the ON2:Pd:ON3 duplex and subsequent loss of the bridging Pd2+ ion at the 
low ionic strength employed. A small sample was, however, treated as described above for ON12:Pd2 
and analyzed by ESI-MS (data presented as supporting information). Oligonucleotides ON2, ON3 and 
ON2:Pd were detected, suggesting that Pd2+ is coordinated at the desired site but the ON2:Pd:ON3 
duplex is not quite as stable as ON12:Pd2.  
< Figure 3 > 
 
2.5. Thermal stability of the modified oligonucleotide duplexes 
 Melting temperatures for the Pd2+-containing duplexes ON12:Pd2 and ON2:Pd:ON3, as well 
as their non-metallated counterparts ON12 and ON2:ON3, were measured in either a 20 mM 
cacodylate buffer (pH = 7.4, for ON12 and ON12:Pd2) or a 20 mM phosphate buffer (pH = 7.2, for 
ON2:ON3 and ON2:Pd:ON3). The oligonucleotide concentrations were 6.0 μM for ON1 (3.0 μM for 
ON12) and 3.0 μM for ON2 and ON3. The ionic strength of the samples was adjusted to 0.1 M with 
NaClO4. With both of the non-metallated oligonucleotide duplexes, typical sigmoidal melting curves 
were obtained, the Tm being 45.9 °C for ON12 and 36.3 °C for ON2:ON3 (Fig. 4). The palladated 
duplexes, on the other hand, behaved quite differently: the melting temperature of ON12:Pd2 was 
too high to be determined whereas with ON2:Pd:ON3 no stabilization over ON2:ON3 was observed. 
Similar results have previously been obtained with 2´-O-methyl-RNA oligonucleotides incorporating 
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2,6-bis(3,5,-dimethylpyrazol-1-yl)purine as the metal-ion-chelating nucleobase. In that case, 10 °C 
stabilization upon addition of 1 eq. of K2PdCl4 was obtained with uracil as the opposite base, but only 
when the metal-ion-mediated base pair was placed at a terminal position.[26] Presumably both of 
these Pd2+-mediated base pairs deviate from the optimal geometry required by the base stack and 
this deviation is better tolerated in a terminal than in an intrastrand position. 
< Figure 4 > 
While impossible to quantify accurately, it is evident that the difference between the thermal 
stabilities of ON12:Pd2 and ON12 is vastly greater than what has been previously reported for any 
oligonucleotide structure with Pd2+ as the bridging metal ion. The reason for this discrepancy could 
be the different preparation of the samples. In the present study, Pd2+-carrying duplexes were 
synthesized and purified prior to the measurements, in contrast to the more common method of 
simply adding Pd2+ salt to a dilute sample containing both strands of the duplex. As discussed above, 
this method may fail to afford the thermodynamic product due to the relatively slow ligand-
exchange reactions of Pd2+. To test this hypothesis, the melting temperature of ON12 was measured 
in the presence of 2 eq. (6.0 μmol L.1) of K2PdCl4 (Fig. 4A). The Tm was somewhat lower than the one 
obtained in the absence of Pd2+ (41.5 and 45.9 °C, respectively). Clearly, mixing dilute solutions of 
ON1 and K2PdCl4 at neutral pH does not result in significant formation of the desired ON12:Pd2 
duplex. 
 
2.6. Secondary structure of the modified oligonucleotide duplexes 
 To probe the secondary structure of the modified duplexes and the possible changes 
induced by Pd2+ coordination, CD spectra of ON12, ON2:ON3, ON12:Pd2 and ON2:Pd:ON3 were 
recorded under the same conditions as described above for the Tm measurements (Figs. 5 and 6). In 
all cases, a negative band at 275 nm was observed at low temperatures, consistent with an (S)-GNA 
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double helix.[27] The other previously reported negative band (at 220 nm) was hardly detectable but 
ON12 exhibited a prominent negative band at 247 nm. This band was not observed with ON12:Pd2 
and the band at 275 nm was also less prominent, suggesting partial unwinding of the double helix 
upon formation of the terminal Pd2+-mediated base pairs. In contrast, the spectra of ON2:ON3 and 
ON2:Pd:ON3 were very similar. As expected, heating resulted in gradual decrease of the CD signals 
with all the oligonucleotides. In the case of ON12:Pd2, however, some ellipticity persisted even at 90 
°C, in line with the high thermal stability of this oligonucleotide. In other words, while the terminal 
Pd2+-mediated base pairs of ON12:Pd2 disrupt the helical secondary structure, they still greatly 
stabilize the duplex. This stabilization is attributable to the two Pd-N bonds formed between the 
terminal thymine residues and the Pd2+:pyridine-2,6-dicarboxamide chelates. Evidently their bond 
energy is greater than the energy cost for (partial) unwinding of the double helix. 
< Figure 5 > 
< Figure 6 > 
 
2.7. Conclusions 
 Formation of Pd2+-mediated base pairs within an oligonucleotide duplex has been 
demonstrated. At the termini of a short duplex, such base pairs may be highly stabilizing even if they 
are not easily accommodated in the base stack of the double helix. For realization of its potential as 
the bridging metal ion, however, Pd2+ has to be firmly attached to a predetermined site of one 
strand of the duplex prior to hybridization. Attempts to introduce Pd2+ to mixtures of 
oligonucleotides in situ under typical conditions of hybridization studies are not likely to afford the 
desired Pd2+-mediated duplex in a practical yield. 
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3. Experimental part 
3.1 . General 
 Preparation of the GNA phosphoramidite building blocks of the four canonical nucleobases 
has been described in the literature.[21-23] The other reagents were commercial products that were 
used as received. Solvents were dried over 3 Å molecular sieves and trimethylamine over calcium 
hydride. 1H, 13C and 31P NMR spectra: Bruker Avance 500- or 400-MHz NMR spectrometer; δ in ppm 
rel. to Me4Si (for 
1H and 13C) or orthophosphoric acid (for 31P) as external standard, J in Hz. HR-ESI-
MS: Bruker Daltonics micrOTOF-Q mass spectrometer; in m/z. UV spectra: Perkin-Elmer Lambda 35 
UV-vis spectrophotometer. CD spectra: Applied Photophysics Chirascan spectropolarimeter. 
 
3.2. Syntheses 
 Diethyl (S)-4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]pyridine-2,6-dicarboxylate (2). 4-
Hydroxypyridine-2,6-dicarboxylate (0.50 g, 2.09 mmol), (R)-2,2-Dimethyl-1,3-dioxolane-4-methanol 
p-toluenesulfonate (0.72 g, 2.5 mmol) and potassium carbonate (1.03 g, 7.45 mmol) were suspended 
in anhydrous DMF (20 mL). The mixture was stirred at 70 °C for 96 h, after which it was evaporated 
to dryness. The residue was dissolved in CH2Cl2 (100 mL) and washed with water (100 mL). The 
organic layer was dried with Na2SO4 and evaporated to dryness. The crude product thus obtained 
was purified on a silica gel column eluting with a mixture of MeOH and CH2Cl2 (6:94, v/v). Yield 0.61 g 
(82%). 1H-NMR (400 MHz, CDCl3): 7.77 (s, 2H, Pyr-H3 & -H5), 4.48 (m, 1H, dioxolane-H5), 4.43 (q, J = 
7.1, 4H, CO2CH2CH3), 4.20-4.09 (m, 3H, dioxolane-H4 & PyrOCH2), (dd, J = 5.8, 8.6, 1H, dioxolane-H4), 
1.42 (s, 3H, dioxolane-CH3), 1.41 (t, J = 7.1, 6H, CO2CH2CH3), 1.36 (s, 3H, dioxolane-CH3). 
13C-NMR 
(100 MHz, CDCl3): 166.5 (2C, CONH2), 164.5 (Pyr-C4), 150.3 (2C, Pyr-C2 & -C6), 114.3 (2C, Pyr-C3 & -
C5), 110.1 (dioxolane-C2), 73.4 (dioxolane-C5), 69.3 (PyrOCH2), 66.3 (dioxolane-C4), 62.3 (2C, 
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CO2CH2CH3), 26.7 (dioxolane-CH3), 25.2 (dioxolane-CH3), 14.2 (2C, CO2CH2CH3). HR-ESI-MS: 354.1547 
([M + H]+, C17H24NO7
+; calc. 354.1547). 
  (S)-1-[(4,4´-Dimethoxytrityl)oxy]-3-{[2,6-bis(ethoxycarbonyl)pyridin-4-yl]oxy}propan-2-yl (2-
cyanoethyl) diisopropylphosphoramidite (4). Compound 2 (0.61 g, 1.73 mmol) was dissolved in a 
mixture of 37% aq. HCl (0.40 mL), MeCN (4.0 mL) and water (4.0 mL). The mixture was stirred at 
room temperature for 16 h, after which it was evaporated to dryness. The residue was coevaporated 
from toluene (10 mL) and anhydrous pyridine (3 ? 10 mL) and finally redissolved in anhydrous 
pyridine (10 mL). 4,4´-Dimethoxytrityl chloride (0.65 g, 1.9 mmol) was added and the resulting 
mixture stirred at room temperature for 16 h, after which it was concentrated under reduced 
pressure. The oily residue was diluted with CH2Cl2 (100 mL) and washed with saturated aq. NaHCO3 
(100 mL). The organic layer was dried with Na2SO4 and evaporated to dryness. The crude product 
thus obtained was purified on a silica gel column eluting with a mixture of Et3N, MeOH and CH2Cl2 
(1:3:96, v/v). The purified intermediate 3 (0.274 g, 0.445 mmol), anhydrous Et3N (311 μL, 2.23 mmol) 
and 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite (120 ?L, 0.496 mmol) were dissolved in 
anhydrous CH2Cl2 (1.5 mL). The resulting mixture stirred under N2 at room temperature for 2 h, after 
which it was diluted with CH2Cl2 (100 mL) and washed with saturated aq. NaHCO3 (100 mL). The 
organic layer was dried with Na2SO4 and evaporated to dryness. NMR analysis revealed the product 
thus obtained to be of sufficient purity. Yield 0.3484 g (25%) as two diastereomers in approximately 
1:1 ratio. 1H-NMR (400 MHz, CDCl3, diastereomer A): 7.78 (s, 2H, Pyr-H3 & -H5), 7.44 (m, 2H, Ph-H2 & 
-H6), 7.31 (m, 4H, MeOPh-H2 & -H6), 7.27 (m, 2H, Ph-H3 & -H5), 7.23 (t, J = 5.0, 1H, Ph-H4), 6.80 (d, J 
= 8.5, 4H, MeOPh-H3 and & -H5), 4.48 (q, J = 7.1, 4H, CO2CH2CH3), 4.37-4.18 (m, 3H, PyrOCH2 & 
CH2CH(OP)CH2), 3.78 (s, 6H, OCH3), 3.74 (m, 1H, POCH2), 3.70 (m, 1H, POCH2), 3.66-3.47 (m, 2H, 
NCHCH3), 3.36 (dd, J = 9.6, 5.1, 1H, DMTrOCH2), 3.29 (dd, J = 9.4, 6.2, 1H, DMTrOCH2), 2.61 (t, J = 6.4, 
2H, CH2CN), 1.46 (t, J = 7.0, 6H, CO2CH2CH3), 1.14 (d, J = 5.6, 6H, NCHCH3), 1.07 (d, J = 6.7, 6H, 
NCHCH3). 
1H-NMR (400 MHz, CDCl3, diastereomer B): 7.74 (s, 2H, Pyr-H3 & -H5), 7.42 (m, 2H, Ph-H2 
& -H6), 7.31 (m, 4H, MeOPh-H2 & -H6), 7.27 (m, 2H, Ph-H3 & -H5), 7.19 (t, J = 6.3, 1H, Ph-H4), 6.82 
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(d, J = 8.1, 4H, MeOPh-H3 and & -H5), 4.48 (q, J = 7.1, 4H, CO2CH2CH3), 4.37-4.18 (m, 3H, PyrOCH2 & 
CH2CH(OP)CH2), 3.82 (m, 1H, POCH2), 3.78 (s, 6H, OCH3), 3.75 (m, 1H, POCH2), 3.66-3.47 (m, 2H, 
NCHCH3), 3.40 (m, 2H, DMTrOCH2), 2.47 (t, J = 6.5, 2H, CH2CN), 1.46 (t, J = 7.2, 6H, CO2CH2CH3), 1.18 
(d, J = 7.2, 6H, NCHCH3), 1.16 (d, J = 6.1, 6H, NCHCH3). 
13C-NMR (100 MHz, CDCl3, diastereomer A): 
166.8 (2C, CONH2), 164.7 (Pyr-C4), 158.5 (2C, MeOPh-C4), 150.2 (2C, Pyr-C2 & -C6), 144.7 (Ph-C1), 
135.9 (MeOPh-C1), 135.8 (MeOPh-C1), 130.0 (2C, MeOPh-C2 & -C6), 130.0 (MeOPh-C2 & -C6), 128.1 
(2C, Ph-C3 & -C5), 127.8 (2C, Ph-C2 & -C6), 126.8 (Ph-C4), 117.6 (CN), 114.5 (2C, Pyr-C3 & -C5), 113.1 
(4C, MeOPh-C3 & -C5), 86.2 (Ar3C), 71.5 (d, J = 16.9, CH2CH(OP)CH2), 69.4 (d, J = 4.5, PyrOCH2), 63.1 
(d, J = 4.1, DMTrOCH2), 62.4 (2C, CO2CH2CH3), 58.2 (d, J = 18.4, POCH2), 55.2 (2C, OCH3), 43.2 (d, J = 
12.7, 2C, NCHCH3), 24.6 (2C, NCHCH3), 24.5 (2C, NCHCH3), 20.2 (d, J = 7.1, CH2CN), 14.2 (2C, 
CO2CH2CH3). 
13C-NMR (100 MHz, CDCl3, diastereomer B): 166.7 (2C, CONH2), 164.7 (Pyr-C4), 158.6 
(2C, MeOPh-C4), 150.2 (2C, Pyr-C2 & -C6), 144.6 (Ph-C1), 135.8 (MeOPh-C1), 135.8 (MeOPh-C1), 
130.0 (4C, MeOPh-C2 & -C6), 128.1 (2C, Ph-C3 & -C5), 127.8 (2C, Ph-C2 & -C6), 126.9 (Ph-C4), 117.5 
(CN), 114.3 (2C, Pyr-C3 & -C5), 113.1 (4C, MeOPh-C3 & -C5), 86.3 (Ar3C), 71.2 (d, J = 16.0, 
CH2CH(OP)CH2), 69.2 (d, J = 2.3, PyrOCH2), 63.0 (d, J = 3.9, DMTrOCH2), 62.4 (2C, CO2CH2CH3), 58.3 (d, 
J = 18.8, POCH2), 55.2 (2C, OCH3), 43.2 (d, J = 12.5, 2C, NCHCH3), 24.7 (2C, NCHCH3), 24.6 (2C, 
NCHCH3), 20.3 (d, J = 6.9, CH2CN), 14.2 (2C, CO2CH2CH3). 
31P-NMR (162 MHz, CDCl3, diastereomer A): 
149.9. 31P-NMR (162 MHz, CDCl3, diastereomer B): 150.1. HR-ESI-MS: 838.3376 ([M + Na]
+, 
C44H54N3NaO10P
+; calc. 838.3439). 
 (S)-1-[(4,4´-Dimethoxytrityl)oxy]-3-[(2,6-dicarbamoylpyridin-4-yl)oxy]propan-2-yl (2-
cyanoethyl) diisopropylphosphoramidite (1). Compound 4 (115 mg, 0.141 mmol) was dissolved in 7 
M methanolic ammonia. The mixture was stirred at room temperature for 16 h, after which all 
volatiles were removed in vacuum. Yield 106 mg (near quantitative). 1H-NMR (500 MHz, CDCl3, 
diastereomer A): 7.87 (s, 2H, Pyr-H3 & -H5), 7.67 (d, J = 3.4 Hz, 2H, CONH), 7.45 (m, 2H, Ph-H2 & -
H6), 7.33 (m, 4H, MeOPh-H2 & -H6), 7.28 (m, 2H, Ph-H3 & -H5), 7.22 (t, J = 7.3, 1H, Ph-H4), 6.85 (d, J 
= 8.5, 4H, MeOPh-H3 and & -H5), 5.94 (d, J = 3.7, 2H, CONH), 4.46 (m, 1H, CH2CH(OP)CH2), 4.33 (m, 
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2H, PyrOCH2), 3.82 (s, 6H, OCH3), 3.77 (m, 1H, POCH2), 3.71 (m, 1H, POCH2), 3.67-3.50 (m, 2H, 
NCHCH3), 3.36 (dd, J = 9.9, 4.9, 1H, DMTrOCH2), 3.29 (dd, J = 9.4, 5.9, 1H, DMTrOCH2), 2.50 (ddd, J = 
6.5, 6.3, 2.1, 2H, CH2CN), 1.17 (d, J = 7.0, 6H, NCHCH3), 1.08 (d, J = 6.7, 6H, NCHCH3). 
1H NMR (500 
MHz, CDCl3, diastereomer B): 7.85 (s, 2H, Pyr-H3 & -H5), 7.66 (d, J = 3.7 Hz, 2H, CONH), 7.44 (m, 2H, 
Ph-H2 & -H6), 7.33 (m, 4H, MeOPh-H2 & -H6), 7.28 (m, 2H, Ph-H3 & -H5), 7.23 (t, J = 7.3, 1H, Ph-H4), 
6.83 (d, J = 8.8, 4H, MeOPh-H3 and & -H5), 5.92 (d, J = 3.7, 2H, CONH), 4.32 (m, 2H, PyrOCH2), 4.26 
(m, 1H, CH2CH(OP)CH2), 3.84 (m, 1H, POCH2), 3.81 (s, 6H, OCH3), 3.78 (m, 1H, POCH2), 3.67-3.50 (m, 
2H, NCHCH3), 3.43 (dd, J = 9.7, 4.4, 1H, DMTrOCH2), 3.38 (dd, J = 10.5, 5.6, 1H, DMTrOCH2), 2.65 
(ddd, J = 6.6, 6.4, 0.7, 2H, CH2CN), 1.19 (d, J = 7.1, 6H, NCHCH3), 1.18 (d, J = 7.3, 6H, NCHCH3). 
13C-
NMR (125 MHz, CDCl3, diastereomer A): 167.6 (Pyr-C4), 165.7 (2C, CONH2), 158.5 (2C, MeOPh-C4), 
150.5 (2C, Pyr-C2 & -C6), 144.7 (Ph-C1), 135.8 (2C, MeOPh-C1), 130.0 (2C, MeOPh-C2 & -C6), 130.0 
(2C, MeOPh-C2 & -C6), 128.1 (2C, Ph-C3 & -C5), 127.8 (2C, Ph-C2 & -C6), 126.8 (Ph-C4), 117.7 (CN), 
113.1 (4C, MeOPh-C3 & -C5), 111.9 (2C, Pyr-C3 & -C5), 86.2 (Ar3C), 71.1 (d, J = 16.1, CH2CH(OP)CH2), 
69.3 (d, J = 2.2, PyrOCH2), 63.1 (d, J = 3.8, DMTrOCH2), 58.3 (d, J = 18.4, POCH2), 55.2 (2C, OCH3), 43.2 
(d, J = 12.6, 2C, NCHCH3), 24.6 (2C, NCHCH3), 24.5 (2C, NCHCH3), 20.3 (d, J = 6.9, CH2CN). 
13C-NMR 
(125 MHz, CDCl3, diastereomer B): 167.7 (Pyr-C4), 165.6 (2C, CONH2), 158.5 (2C, MeOPh-C4), 150.5 
(2C, Pyr-C2 & -C6), 144.7 (Ph-C1), 135.9 (MeOPh-C1), 135.8 (MeOPh-C1), 130.1 (4C, MeOPh-C2 & -
C6), 128.1 (2C, Ph-C3 & -C5), 127.9 (2C, Ph-C2 & -C6), 126.9 (Ph-C4), 117.5 (CN), 113.1 (4C, MeOPh-
C3 & -C5), 111.8 (2C, Pyr-C3 & -C5), 86.3 (Ar3C), 71.4 (d, J = 16.8, CH2CH(OP)CH2), 69.5 (d, J = 4.7, 
PyrOCH2), 63.0 (d, J = 3.1, DMTrOCH2), 58.3 (d, J = 18.9, POCH2), 55.2 (2C, OCH3), 43.2 (d, J = 12.5, 2C, 
NCHCH3), 24.7 (2C, NCHCH3), 24.6 (2C, NCHCH3), 20.2 (d, J = 7.1, CH2CN). 
31P-NMR (202 MHz, CDCl3, 
diastereomer A): 149.8. 31P-NMR (202 MHz, CDCl3, diastereomer B): 150.1. HR-ESI-MS: 780.3130 ([M 
+ Na]+, C40H48N5NaO8P
+; calc. 780.3138). 
 (R)-4-(2,3-Dihydroxypropoxy)pyridine-2,6-dicarboxamide (5). Compound 2 (0.50 g, 1.41 
mmol) was dissolved in a mixture of 37% aq. HCl (0.50 mL), MeCN (5.0 mL) and water (5.0 mL). The 
mixture was stirred at room temperature for 16 h, after which it was evaporated to dryness. The 
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residue was dissolved in 7 M methanolic ammonia and the mixture stirred at room temperature for 
16 h, after which all volatiles were removed in vacuum. Yield 0.36 g (near quantitative). 1H NMR (500 
MHz, (D6)DMSO): 8.85 (s, 2H, NH2), 7.71 (s, 2H, NH2), 7.67 (s, 2H, Pyr-H3 & -H5), 5.09 (s, 1H, 
CH2CH(OH)CH2), 4.76 (s, 1H, CH2OH), 4.25 (dd, 1H, J = 10.2, 3.0, PyrOCH2), 4.09 (dd, 1H, J = 9.0, 6.6, 
PyrOCH2), 3.84 (m, H, CH2CH(OH)CH2), 3.47 (m, 2H, HOCH2). 
13C NMR (125 MHz, (D6)DMSO): 167.8 
(Pyr-C4), 165.7 (2C, CONH2), 151.6 (2C, Pyr-C2 & -C6), 110.7 (2C, Pyr-C3 & -C5), 70.9 (PyrOCH2), 70.1 
(CH2CH(OH)CH2), 62.8 (HOCH2)). HR-ESI-MS: 278.0742 ([M + Na]
+,C10H13N3NaO5
+; calc. 278.0747). 
 General procedure for preparation of solid supports for the synthesis of GNA 
oligonucleotides. An appropriately protected GNA counterpart of a 2´-deoxynucleoside (0.15 mmol) 
was dissolved in anhydrous pyridine (8.0 mL). Succinic anhydride (0.60 mmol) and DMAP (cat.) were 
added and the resulting mixture stirred at room temperature for 16 h, after which it was evaporated 
to dryness. The residue was dissolved in CH2Cl2 (40 mL) and washed with saturated aq. NaHCO3 (40 
mL). The organic layer was dried with Na2SO4 and evaporated to dryness. An approximately 20 μmol 
portion of the crude product thus obtained was dissolved in anhydrous DMF (0.50 mL). HBTU (7.6 
mg, 20 μmol) and DIPEA (7.0 μL, 41 μmol) were added and the resulting solution transferred to a 
microcentrifuge tube containing long chain alkylamine-CPG (100 mg). The tube was shaken at room 
temperature for 24 h, after which the CPG was transferred to an oligonucleotide synthesizer column 
and washed with anhydrous DMF (15 mL) and MeCN (15 mL). The unreacted amino groups of the 
CPG support were acetylated by treatment with a mixture of 2,6-lutidine (0.20 mL), Ac2O (0.20 mL), 
N-methylimidazole (0.32 mL) and THF (3.28 mL)  at room temperature for 3 min. Finally, the support 
was washed with anhydrous MeCN (15 mL) and CH2Cl2 (15 mL). 
 For quantification of its loading, 5.0 mg of the CPG support was placed in a microcentrifuge 
tube and 3% solution of dichloroacetic acid in CH2Cl2 (1.0 mL) was added. The resulting orange 
solution was separated and the above treatment repeated until the acidic solution remained 
colourless. The aliquots were then combined and diluted to 25.0 mL with CH2Cl2. The absorbance of 
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this solution was then measured at 503 nm and the loading calculated based on the known molar 
absorptivity of 0.076 L μmol-1 cm-1. The loadings obtained by this method were 46.1, 48.6, 41.9 and 
38.9 μmol g-1 for A, C, G and T, respectively. 
 Oligonucleotide synthesis. The oligonucleotides were assembled by an automated 
synthesizer on CPG supports prepared as described above. Conventional phosphoramidite strategy 
with 5-benzylthio-1H-tetrazole as the activator and 300 s coupling time was used throughout the 
sequences. Based on the trityl response, the coupling yields for the modified building block 1 and the 
canonical building blocks were 44% and more than 98%, respectively. Oligonucleotides ON1 and 
ON2 were released from the supports and the phosphate and base protections removed by a 35 min 
treatment with 16% aq. ammonia at 55 °C. In the case of ON3, 20% aq. methylamine was used 
instead. To prevent nucleophilic attack of 3´-OH on the vicinal phosphate during aminolysis, this step 
was carried out with the 3´-O-DMTr protection in place. This protecting group was finally removed 
by a 60 min treatment with 80% aq. acetic acid at room temperature. 
 The crude oligonucleotides were purified by RP-HPLC on a Thermo Scientific Aquasil C18 
column (150 ? 4 mm, 5 μm), eluting with a mixture of acetonitrile (linear gradient of 0 to 30% over 
30 min) and 0.10 M triethylammonium acetate. The flow rate was 1.0 mL min-1 and the detection 
wavelength 260 nm. The purified oligonucleotides were characterized by electrospray ionization 
mass spectrometry (ESI-MS, mass spectra presented as supporting information) and their 
concentrations estimated UV-spectrophotometrically based on absorbance at 260 nm. The molar 
absorptivities were calculated by an implementation of the nearest-neighbors method assuming the 
hypochromicities of GNA and DNA oligonucleotides to be equal.[24, 25] 
 Preparation of the Pd2+-carrying oligonucleotide ON12:Pd2. A 215 μM aq. solution of 
oligonucleotide ON1 (300 μL, 64.5 nmol) was lyophilized and the residue dissolved in 2.0 mM aq. 
solution of K2PdCl4 (48.4 μL, 96.8 nmol). After vigorous vortexing, the mixture was incubated at room 
temperature for 16 h. Phosphate buffer (48.4 μL, 120 mM, pH 7.2) was added and the mixture 
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incubated at room temperature for another 12 h. The product mixture was fractioned by RP HPLC on 
a Thermo Scientific Aquasil C18 column (150 ? 4 mm, 5 μm), eluting with a mixture of acetonitrile 
(linear gradient of 0 to 30% over 30 min) and 60 mM phosphate buffer (pH 7.2). The flow rate was 
1.0 mL min-1 and the detection wavelength 260 nm. The main fraction, eluting at 12.5 min, was 
collected and desalted by RP HPLC on the same column, eluting with a mixture of acetonitrile (0% for 
the first 6 min, followed by a linear gradient to 60% over 0.5 min and isocratic elution at 60% for 9 
min) and water. Formation of the desired structure ON12:Pd2 was verified by ESI-MS (mass spectrum 
presented as supporting information). 
 Preparation of the Pd2+-carrying oligonucleotide ON2:Pd:ON3. A 399 μM aq. solution of 
oligonucleotide ON2 (300 μL, 119.7 nmol) was lyophilized and the residue dissolved in 2.0 mM aq. 
solution of K2PdCl4 (65.8 μL, 131.6 nmol). After vigorous vortexing, the mixture was incubated at 
room temperature for 16 h and then lyophilized. The residue was dissolved in a 280 μM aq. solution 
of oligonucleotide ON3 (427.5 μL, 119.0 nmol) and the resulting solution diluted with phosphate 
buffer (427.5 μL, 120 mM, pH 7.2). After incubation for 1 h at room temperature, the product 
mixture was fractioned by RP HPLC under the same conditions as described above for ON12:Pd2. The 
main fraction, eluting at 10.4 min, was collected and used as such in the hybridization studies. 
Attempts to desalt ON2:Pd:ON3 were unsuccessful. For characterization, a small sample was treated 
as described above for ON12:Pd2 and analyzed by ESI-MS (data presented as supporting 
information). Oligonucleotides ON2, ON3 and ON2:Pd were detected, consistent with formation of 
the desired structure ON2:Pd:ON3. 
 
References 
[1] G.H. Clever, C. Kaul, T. Carell, Angew. Chem. Int. Ed. 46 (2007) 6226-6236. 
[2] G.H. Clever, M. Shionoya, Coord. Chem. Rev. 254 (2010) 2391-2402. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
17 
 
[3] J. Müller, Eur. J. Inorg. Chem. 2008 (2008) 3749-3763. 
[4] J. Müller, Nature 444 (2006) 698-698. 
[5] P. Scharf, J. Müller, ChemPlusChem 78 (2013) 20-34. 
[6] Y. Takezawa, M. Shionoya, Acc. Chem. Res. 45 (2012) 2066-2076. 
[7] M. Shionoya, K. Tanaka, Curr. Opin. Chem. Biol. 8 (2004) 592-597. 
[8] S. Johannsen, S. Paulus, N. Düpre, J. Müller, R.K.O. Sigel, J. Inorg. Biochem. 102 (2008) 1141-1151. 
[9] F.-A. Polonius, J. Müller, Angew. Chem. Int. Ed. 46 (2007) 5602-5604. 
[10] J. Reedijk, Eur. J. Inorg. Chem. 2009 (2009) 1303-1312. 
[11] A.M. Pizarro, P.J. Sadler, in:  Nucleic Acid-Metal Ion Interactions, The Royal Society of Chemistry, 
2009, pp. 350-416. 
[12] B. Lippert, BioMetals 5 (1992) 195-208. 
[13] M. Tasaka, K. Tanaka, M. Shiro, M. Shionoya, Supramol. Chem. 13 (2001) 671-675. 
[14] Y. Takezawa, K. Tanaka, M. Yori, S. Tashiro, M. Shiro, M. Shionoya, J. Org. Chem. 73 (2008) 6092-
6098. 
[15] J. Müller, E. Freisinger, P. Lax, D.A. Megger, F.-A. Polonius, Inorg. Chim. Acta 360 (2007) 255-
263. 
[16] S. Taherpour, T. Lönnberg, J. Nucleic Acids 2012 (2012) Article ID 196485. 
[17] O. Golubev, T. Lönnberg, H. Lönnberg, Helv. Chim. Acta 96 (2013) 1658-1669. 
[18] O. Golubev, T. Lönnberg, H. Lönnberg, J. Inorg. Biochem. 139 (2014) 21-29. 
[19] O. Golubev, T. Lönnberg, H. Lönnberg, Molecules 19 (2014) 16976-16986. 
[20] K. Tanaka, M. Shionoya, J. Org. Chem. 64 (1999) 5002-5003. 
[21] L. Zhang, A.E. Peritz, P.J. Carroll, E. Meggers, Synthesis 2006 (2006) 645-653. 
[22] M.K. Schlegel, E. Meggers, J. Org. Chem. 74 (2009) 4615-4618. 
[23] O.M. Ali, H.H. Amer, A.A.H. Abdel-Rahman, J. Chem. Res.-S (2007) 281-283. 
[24] M.J. Cavaluzzi, P.N. Borer, Nucleic Acids Res. 32 (2004) e13-e13. 
[25] A.V. Tataurov, Y. You, R. Owczarzy, Biophys. Chem. 133 (2008) 66-70. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
18 
 
[26] S. Taherpour, H. Lönnberg, T. Lönnberg, Org. Biomol. Chem. 11 (2013) 991-1000. 
[27] L. Zhang, A. Peritz, E. Meggers, J. Am. Chem. Soc. 127 (2005) 4174-4175. 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
19 
 
Table 1 Structures of the GNA oligonucleotides used in this study. 
 
Scheme 1 Synthesis of the modified GNA phosphoramidite building block 1. Reagents and 
conditions: (a) K2CO3, DMF; (b) HCl, MeCN, H2O; (c) DMTrCl, pyridine; (d) 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite, Et3N, CH2Cl2; (e) NH3, MeOH. 
 
Scheme 2 Preparation of solid supports for the synthesis of GNA oligonucleotides. Reagents and 
conditions: (a) succinic anhydride, DMAP, pyridine; (b) LCAA-CPG, HBTU, DIPEA, DMF. 
 
Scheme 3 Synthesis of the unprotected monomer 5. Reagents and conditions: (a) HCl, MeCN, H2O; 
(b) NH3, MeOH. 
 
Figure 1 HPLC traces for (A) purified ON1 and (B) product mixture of the reaction of ON1 with 1.5 eq. 
of K2PdCl4; Thermo Scientific Aquasil C18 column (150 ? 4 mm, 5 μm); flow rate = 1.0 mL min-1; linear 
gradient (0 to 30% over 30 min) of MeCN in 60 mM phosphate buffer (pH = 7.2). 
 
Figure 2 (A) Proposed structure of ON12:Pd2 and (B) calculated and observed mass spectra for its 
tetraanion. 
 
Figure 3 HPLC traces for (A) purified ON2, (B) purified ON3, (C) product mixture of the reaction of 
ON2 and 1.1 eq. of K2PdCl4, followed by 1.0 eq. of ON3 and (D) reinjection of the faster-eluting peak 
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of chromatogram C; Thermo Scientific Aquasil C18 column (150 ? 4 mm, 5 μm); flow rate = 1.0 mL 
min-1; linear gradient (0 to 30% over 30 min) of MeCN in 60 mM phosphate buffer (pH = 7.2). 
 
Figure 4 UV melting profiles for (A) ON12 (?), ON12:Pd2 (?) and ON12 with 2.0 eq. of K2PdCl4 added 
in situ (?) and (B) ON2:ON3 (?) and ON2:Pd:ON3 (?); [ON1] = 6.0 μM; [ON2] = [ON3] = 3.0 μM; 
[Pd2+] = 0 / 3.0 / 6.0 μM; I(NaClO4) = 0.10 M; pH = 7.4. 
 
Figure 5 CD spectra of oligonucleotide duplexes (A) ON12 and (B) ON12:Pd2, recorded at 10 °C 
intervals between 10 and 90 °C; [ON12] = [ON12:Pd2] = 3.0 μM; pH = 7.4 (20 mM cacodylate buffer); 
I(NaClO4) = 0.10 M. 
 
Figure 6 CD spectra of oligonucleotide duplexes (A) ON2:ON3 and (B) ON2:Pd:ON3, recorded at 10 
°C intervals between 10 and 90 °C; [ON2:ON3] = [ON2:Pd:ON3] = 3.0 μM; pH = 7.2 (20 mM 
phosphate buffer); I(NaClO4) = 0.10 M. 
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Table 1 
 
 Sequence  
ON1 5´-XCGCGT-3´ 
 
ON2 5´-CGCXGGC-3´ 
ON3 5´-GCCTGCG-5´ 
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Graphical abstract 
 
Terminal Pd2+-mediated base pairs between pyridine-2,6-dicarboxamide and thymine greatly 
enhance the thermal stability of short GNA oligonucleotides relative to their metal-free 
counterparts. The effect was only observed with metallated oligonucleotides isolated prior to the 
hybridization studies, not when Pd2+ salt was added to the oligonucleotide solution in situ. 
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HIGHLIGHTS 
? Pd2+-mediated base-pairing within oligonucleotides has been demonstrated. 
? At the termini of a duplex, Pd2+-mediated base-pairing is highly stabilizing. 
? Mixing dilute oligonucleotide and Pd2+ solutions may not afford the desired structure. 
